This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1994 Jun 3;264(5164):1413-4.

doi: 10.1126/science.8197454.

A biochemical function for ras--at last

A Hall¹

Affiliations

PMID: 8197454
DOI: 10.1126/science.8197454

Comment

A biochemical function for ras--at last

A Hall. Science. 1994.

. 1994 Jun 3;264(5164):1413-4.

doi: 10.1126/science.8197454.

Author

A Hall¹

Affiliation

¹ Medical Research Council Laboratory for Molecular Cell Biology, University College London, UK.

PMID: 8197454
DOI: 10.1126/science.8197454

No abstract available

PubMed Disclaimer

Comment on

Activation of Raf as a result of recruitment to the plasma membrane.
Stokoe D, Macdonald SG, Cadwallader K, Symons M, Hancock JF. Stokoe D, et al. Science. 1994 Jun 3;264(5164):1463-7. doi: 10.1126/science.7811320. Science. 1994. PMID: 7811320

Similar articles

Activation of Ras and mitogen-activated protein kinase pathway by terminal complement complexes is G protein dependent.
Niculescu F, Rus H, van Biesen T, Shin ML. Niculescu F, et al. J Immunol. 1997 May 1;158(9):4405-12. J Immunol. 1997. PMID: 9127005
Inhibition by cAMP of Ras-dependent activation of Raf.
Cook SJ, McCormick F. Cook SJ, et al. Science. 1993 Nov 12;262(5136):1069-72. doi: 10.1126/science.7694367. Science. 1993. PMID: 7694367
Hypoxic activation of nuclear factor-kappa B is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2).
Koong AC, Chen EY, Mivechi NF, Denko NC, Stambrook P, Giaccia AJ. Koong AC, et al. Cancer Res. 1994 Oct 15;54(20):5273-9. Cancer Res. 1994. PMID: 7923153
Apoptosis: does stress kill?
Cosulich S, Clarke P. Cosulich S, et al. Curr Biol. 1996 Dec 1;6(12):1586-8. doi: 10.1016/s0960-9822(02)70779-3. Curr Biol. 1996. PMID: 8994820 Review.
MAP kinases ERK1 and ERK2: pleiotropic enzymes in a ubiquitous signaling network.
Robbins DJ, Zhen E, Cheng M, Xu S, Ebert D, Cobb MH. Robbins DJ, et al. Adv Cancer Res. 1994;63:93-116. doi: 10.1016/s0065-230x(08)60399-1. Adv Cancer Res. 1994. PMID: 8036991 Review. No abstract available.

See all similar articles

Cited by

Pharmacological targeting of RAS: Recent success with direct inhibitors.
O'Bryan JP. O'Bryan JP. Pharmacol Res. 2019 Jan;139:503-511. doi: 10.1016/j.phrs.2018.10.021. Epub 2018 Oct 23. Pharmacol Res. 2019. PMID: 30366101 Free PMC article. Review.
RASSF1A Deficiency Enhances RAS-Driven Lung Tumorigenesis.
Schmidt ML, Hobbing KR, Donninger H, Clark GJ. Schmidt ML, et al. Cancer Res. 2018 May 15;78(10):2614-2623. doi: 10.1158/0008-5472.CAN-17-2466. Epub 2018 May 7. Cancer Res. 2018. PMID: 29735543 Free PMC article.
Targeting Bcl-2 based on the interaction of its BH4 domain with the inositol 1,4,5-trisphosphate receptor.
Rong YP, Barr P, Yee VC, Distelhorst CW. Rong YP, et al. Biochim Biophys Acta. 2009 Jun;1793(6):971-8. doi: 10.1016/j.bbamcr.2008.10.015. Epub 2008 Nov 12. Biochim Biophys Acta. 2009. PMID: 19056433 Free PMC article. Review.
The mammalian mitogen activated protein kinase network.
Lenormand P. Lenormand P. Clin Mol Pathol. 1995 Dec;48(6):M292-301. doi: 10.1136/mp.48.6.m292. Clin Mol Pathol. 1995. PMID: 16696026 Free PMC article. No abstract available.
Kinase inhibitors in cancer therapy: a look ahead.
Sedlacek HH. Sedlacek HH. Drugs. 2000 Mar;59(3):435-76. doi: 10.2165/00003495-200059030-00004. Drugs. 2000. PMID: 10776829 Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database